Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
News
life_sciences_scotland_edit

Life Sciences Scotland appoints two MSPs to their Industry Leadership Group

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma

Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …
Appointment
kenneth_c

Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma

MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …
News
28246711066_52e38bc591_z

EMA says pharma industry now more prepared for Brexit

September 27, 2018 Manufacturing and Production, Medical Communications EMA, EU, brexit, products, qppv

In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …
News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
News
29496564944_a9faceb1c2_z

President Trump pledges to fight drug addiction at UN meeting

September 25, 2018 Manufacturing and Production Trump, UN, drugs, illicit drugs, trafficking

President Donald Trump has pledged to fight “the scourge of drug addiction,” as he outlined his commitment to the fight …
News

Roche’s entrectinib shrinks lung tumours with two-year response duration

September 25, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, NSCLC, NSCLC< lung cancer, Roche, entrectinib

Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive …
News
jj_sign_on_wall

J&J pledges to end global TB pandemic

September 25, 2018 Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis

Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …
News
novartis_outside_1

Novartis cuts more than 2500 jobs in Switzerland and the UK

September 25, 2018 Manufacturing and Production Basel, Jobs, Novartis, Switzerland, grimsby, manufacturing

Swiss multinational Novartis are set to cut thousands of jobs across Europe in an effort to boost profitability. The move …
News
astrazeneca_building_white

AstraZeneca chalks up European approval for Imfinzi in locally advanced, unresectable lung cancer

September 25, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MedImmune, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as …
News

Working Life: Jean-Christophe Tellier, CEO of UCB Pharma

September 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, Working Life, feature

Just as his company announced robust H1 2018 financials, UCB’s Jean-Christophe Tellier spoke to Pharmafocus to share his experiences of …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …
News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
Feature

Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected

September 19, 2018 Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma

Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …
News
cruk

Cancer Research UK announces new £14m research hub in London

September 18, 2018 Manufacturing and Production, Research and Development CRUK, Cancer, pharma

Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026